Cargando…

Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients

INTRODUCTION: Invasive pulmonary aspergillosis (IPA) is a potentially lethal opportunistic infection. Old age is one of the important risk factors of IPA. However, data regarding the clinical characteristics and prognostic factors of elderly patients with IPA are limited, with data regarding co-infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lao, Minxi, Zhang, Kaicong, Zhang, Meng, Wang, Qian, Li, Jin, Su, Lei, Ding, Meilin, He, Wen, Gong, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567571/
https://www.ncbi.nlm.nih.gov/pubmed/33116671
http://dx.doi.org/10.2147/IDR.S273946
_version_ 1783596352799768576
author Lao, Minxi
Zhang, Kaicong
Zhang, Meng
Wang, Qian
Li, Jin
Su, Lei
Ding, Meilin
He, Wen
Gong, Yingying
author_facet Lao, Minxi
Zhang, Kaicong
Zhang, Meng
Wang, Qian
Li, Jin
Su, Lei
Ding, Meilin
He, Wen
Gong, Yingying
author_sort Lao, Minxi
collection PubMed
description INTRODUCTION: Invasive pulmonary aspergillosis (IPA) is a potentially lethal opportunistic infection. Old age is one of the important risk factors of IPA. However, data regarding the clinical characteristics and prognostic factors of elderly patients with IPA are limited, with data regarding co-infection of other bacteria or fungi even scarcer. METHODS: We performed a retrospective study of elderly patients (aged≥60) with IPA diagnosed in the First Affiliated Hospital of Sun Yat-sen University from January 2000 to December 2019. Data collection included demographic characteristics, premorbid conditions, underlying diseases, clinical manifestations, therapeutic procedures, and pathogenic detection. Associated factors were analyzed by logistic regression analysis. RESULTS: A total of 97 elderly patients (75 males, 22 females) with IPA were included. The all-cause mortality rate was 36.1% (35/97). Body mass index (BMI) (adjusted odds ratio (OR) 1.27, 95% confidence interval (CI) 1.08–1.50, P=0.01), solid organ malignancy (adjusted OR 5.37, 95% CI 1.35–21.33, P=0.02), and co-infections (adjusted OR 5.73, 95% CI 1.40–23.51, P=0.02) were associated with mortality in the elderly patients with IPA. Nearly, 76.3% (74/97) of the patients developed co-infections. Most of the infections (55/74, 74.3%) involved the lung. A total of 77 strains of bacteria were isolated, and Gram-negative bacteria (63/77, 81.3%) were predominant. Patients with co-infections are older (72.3±7.6 vs 67.4±7.4, P=0.04), prone to admit to the intensive care unit (ICU) (59.5% vs 26.1%, P=0.01), and present lymphopenia (60.8% vs 26.1%, P=0.004). In multivariate analysis, ICU admission (adjusted OR 4.57, 95% CI 1.53–13.67, P=0.01), and lymphopenia (adjusted OR 4.82, 95% CI 1.62–14.38, P=0.01) were significantly associated with co-infection in the elderly patients with IPA. CONCLUSION: IPA is a fatal disease in the elderly population. Co-infection is closely associated with mortality. Lymphopenia could be an indicator for co-infection in the elderly patients with IPA.
format Online
Article
Text
id pubmed-7567571
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75675712020-10-27 Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients Lao, Minxi Zhang, Kaicong Zhang, Meng Wang, Qian Li, Jin Su, Lei Ding, Meilin He, Wen Gong, Yingying Infect Drug Resist Original Research INTRODUCTION: Invasive pulmonary aspergillosis (IPA) is a potentially lethal opportunistic infection. Old age is one of the important risk factors of IPA. However, data regarding the clinical characteristics and prognostic factors of elderly patients with IPA are limited, with data regarding co-infection of other bacteria or fungi even scarcer. METHODS: We performed a retrospective study of elderly patients (aged≥60) with IPA diagnosed in the First Affiliated Hospital of Sun Yat-sen University from January 2000 to December 2019. Data collection included demographic characteristics, premorbid conditions, underlying diseases, clinical manifestations, therapeutic procedures, and pathogenic detection. Associated factors were analyzed by logistic regression analysis. RESULTS: A total of 97 elderly patients (75 males, 22 females) with IPA were included. The all-cause mortality rate was 36.1% (35/97). Body mass index (BMI) (adjusted odds ratio (OR) 1.27, 95% confidence interval (CI) 1.08–1.50, P=0.01), solid organ malignancy (adjusted OR 5.37, 95% CI 1.35–21.33, P=0.02), and co-infections (adjusted OR 5.73, 95% CI 1.40–23.51, P=0.02) were associated with mortality in the elderly patients with IPA. Nearly, 76.3% (74/97) of the patients developed co-infections. Most of the infections (55/74, 74.3%) involved the lung. A total of 77 strains of bacteria were isolated, and Gram-negative bacteria (63/77, 81.3%) were predominant. Patients with co-infections are older (72.3±7.6 vs 67.4±7.4, P=0.04), prone to admit to the intensive care unit (ICU) (59.5% vs 26.1%, P=0.01), and present lymphopenia (60.8% vs 26.1%, P=0.004). In multivariate analysis, ICU admission (adjusted OR 4.57, 95% CI 1.53–13.67, P=0.01), and lymphopenia (adjusted OR 4.82, 95% CI 1.62–14.38, P=0.01) were significantly associated with co-infection in the elderly patients with IPA. CONCLUSION: IPA is a fatal disease in the elderly population. Co-infection is closely associated with mortality. Lymphopenia could be an indicator for co-infection in the elderly patients with IPA. Dove 2020-10-12 /pmc/articles/PMC7567571/ /pubmed/33116671 http://dx.doi.org/10.2147/IDR.S273946 Text en © 2020 Lao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lao, Minxi
Zhang, Kaicong
Zhang, Meng
Wang, Qian
Li, Jin
Su, Lei
Ding, Meilin
He, Wen
Gong, Yingying
Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title_full Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title_fullStr Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title_full_unstemmed Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title_short Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
title_sort clinical features and co-infections in invasive pulmonary aspergillosis in elderly patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567571/
https://www.ncbi.nlm.nih.gov/pubmed/33116671
http://dx.doi.org/10.2147/IDR.S273946
work_keys_str_mv AT laominxi clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT zhangkaicong clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT zhangmeng clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT wangqian clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT lijin clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT sulei clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT dingmeilin clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT hewen clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients
AT gongyingying clinicalfeaturesandcoinfectionsininvasivepulmonaryaspergillosisinelderlypatients